Compounds > 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidinyl)-1-nitrosourea
Page last updated: 2024-08-22

1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidinyl)-1-nitrosourea and Nausea

1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidinyl)-1-nitrosourea has been researched along with Nausea in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benjamin, RS; Bodey, GP; Burgess, MA; Leavens, M; Stewart, DJ; Valdivieso, M1
Casper, ES; Gordon, C; Gralla, RJ; Kalman, LA; Kris, MG; Woodcock, TM1

Other Studies

2 other study(ies) available for 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidinyl)-1-nitrosourea and Nausea

ArticleYear
Phase I study of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea (NSC 95466) in adults with solid tumors.
    Cancer research, 1980, Volume: 40, Issue:10

    Topics: Adolescent; Adult; Aged; Agranulocytosis; Brain Neoplasms; Drug Administration Schedule; Drug Evaluation; Female; Glioblastoma; Glioma; Humans; Hypotension; Male; Middle Aged; Mustard Compounds; Nausea; Neoplasms; Nitrosourea Compounds; Thrombocytopenia

1980
Phase I trial of PCNU.
    Cancer treatment reports, 1983, Volume: 67, Issue:11

    Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Small Cell; Drug Evaluation; Female; Glioma; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Nausea; Neoplasms; Nitrosourea Compounds; Thrombocytopenia

1983